share_log

EyePoint Pharmaceuticals(EYPT.US) 10% Shareholder Buys US$10.49 Million in Common Stock

moomoo News ·  Apr 22 16:40

$EyePoint Pharmaceuticals (EYPT.US)$ 10% Shareholder Cormorant Asset Management, LP purchased 581.77K shares of common stock on Apr 18, 2024 at an average price of $18.03 for a total value of $10.49 million.

This transaction involves other related parties: Chen Bihua and Cormorant Global Healthcare Master Fund, LP.

1713818433350934096.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment